GlassScriptPhysician profile
Pranav M Patel
NPI 1427184175
$12,304.94
in general payments reported to CMS, 2019-2025
23 companies · $605 in 2025
The $605 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,775 · 2020: $105 · 2021: $688 · 2022: $1,771 · 2023: $1,040 · 2024: $6,320 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,064 · Travel and Lodging: $2,536 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,200 · Consulting Fee: $127 · Entertainment: $37.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,064.32 |
| Travel and Lodging | $2,535.67 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,200.00 |
| Consulting Fee | $127.36 |
| Entertainment | $37.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $2,837.65 | 2024 | Accucinch |
| Abbott Laboratories | $2,706.86 | 2019-2025 | Coroflow, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Shockwave Medical, INC | $2,565.75 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $1,524.37 | 2020-2024 | Sapien 3 Ultra Resilia, Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $934.37 | 2020-2025 | Impella |
| Atricure, INC. | $288.65 | 2022 | |
| Novartis Pharmaceuticals Corporation | $237.39 | 2024-2025 | |
| Penumbra, INC. | $234.54 | 2022 | |
| Cardiovascular Systems INC. | $201.26 | 2021-2022 | |
| Jenavalve Technology, INC. | $127.36 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $121.39 | 2021 | |
| Boston Scientific Corporation | $115.51 | 2023-2024 | Watchman Access System, Avvigo Guidance System |
| Opsens INC. | $102.79 | 2023 | Optowire |
| Philips North America LLC | $71.48 | 2024 | (Bs2) Lm Undivided |
| Regeneron Healthcare Solutions, INC. | $45.76 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $39.90 | 2023 | Tr Band, Glidewire, Angio-Seal |
| Medtronic, INC. | $35.66 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Onyx Frontier |
| Amgen INC. | $24.35 | 2023 | Repatha |
| Acist Medical Systems, INC. | $24.04 | 2024 | |
| Sanofi-Aventis U.S. LLC | $20.17 | 2019 | |
| Medtronic Vascular, INC. | $17.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.47 | 2020 | |
| Novo Nordisk INC | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.